Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-10-09

Clinical Trial Update: Duloxetine as an Analgesic Agent in Patients Undergoing Elective Spine Surgery [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating duloxetine as an analgesic in patients undergoing elective spine surgery for intervertebral disc degeneration; results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Duloxetine (DULOXETINE)

Snippet

Sponsor: Serviço de Anestesiologia de Joinville | Conditions: Intervertebral Disc Degeneration | Phase 4 | Status: COMPLETED | Results posted: 2020-10-09